Day One Biopharmaceuticals

DAWN

21.5300.00% ( 0.000 )

Delisted: Apr 27, 16:00:00 (EDT)

Forecast & Rating8 analysts currently cover Day One Biopharmaceuticals, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.50, about 0.1% downside from the current price of $21.53. For you, this means most institutions are cautious on Day One Biopharmaceuticals's outlook. Data as of Apr 8, 2026; for reference only and not investment advice.

Apr 6, 2026

Price forecast

$21.50-0.14%

Forecast & RatingHold

8analysts

Forecast dateApr 20, 2026

Forecast met2.6%

Stock price$21.53

Avg. target$21.5

High target$22

Low target$22

Strong buy

Buy

Hold

Sell

Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.